Clinical significance and immunobiology of IL-21 in autoimmunity

D Long, Y Chen, H Wu, M Zhao, Q Lu - Journal of autoimmunity, 2019 - Elsevier
Abstract Interleukin-21 (IL-21), an autocrine cytokine predominantly produced by follicular
helper T (Tfh) and T helper 17 (Th17) cells, has been proven to play an important role in the …

Genomic alterations driving psoriasis pathogenesis

S Singh, D Pradhan, P Puri, V Ramesh, S Aggarwal… - Gene, 2019 - Elsevier
Psoriasis is an immune mediated inflammatory skin disease with complex etiology involving
interplay between environmental and genetic risk factors as disease initiating event …

Genetic architectures of childhood-and adult-onset asthma are partly distinct

MAR Ferreira, R Mathur, JM Vonk, A Szwajda… - The American Journal of …, 2019 - cell.com
The extent to which genetic risk factors are shared between childhood-onset (COA) and
adult-onset (AOA) asthma has not been estimated. On the basis of data from the UK Biobank …

LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR‐219a‐5p

L Wang, T Luan, S Zhou, J Lin, Y Yang, W Liu… - Cancer …, 2019 - Wiley Online Library
Emerging evidence has suggested that long noncoding RNAs (lncRNA) involved in the
development and progression of cancer. Triple negative breast cancer (TNBC) was an …

Long Noncoding RNA HCP5, a Hybrid HLA Class I Endogenous Retroviral Gene: Structure, Expression, and Disease Associations

JK Kulski - Cells, 2019 - mdpi.com
The HCP5 RNA gene (NCBI ID: 10866) is located centromeric of the HLA-B gene and
between the MICA and MICB genes within the major histocompatibility complex (MHC) class …

Long noncoding RNA HCP5 regulates pancreatic cancer gemcitabine (GEM) resistance by sponging Hsa-miR-214-3p to target HDGF

Y Liu, J Wang, L Dong, L Xia, H Zhu, Z Li… - OncoTargets and …, 2019 - Taylor & Francis
Background Gemcitabine (GEM) is one of the most widely chemotherapy drugs in PC.
However, the chemotherapy resistance always occurs after a period of treatment indicating …

The IL-23/IL-17 pathway in human chronic inflammatory diseases–new insight from genetics and targeted therapies

E Bianchi, L Rogge - Microbes and Infection, 2019 - Elsevier
Chronic inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease,
spondyloarthritis and psoriasis cause significant morbidity and are a considerable burden …

[HTML][HTML] The expanding role of anti–IL-12 and/or anti–IL-23 antibodies in the treatment of inflammatory bowel disease

A Kashani, DA Schwartz - Gastroenterology & hepatology, 2019 - ncbi.nlm.nih.gov
Abstract The interleukin (IL)-12/IL-23 pathway is one of many proposed mechanistic
pathways of intestinal inflammation. Earlier studies introduced IL-12 as a major cytokine in …

Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis

A Aterido, JD Cañete, J Tornero, C Ferrándiz… - Annals of the …, 2019 - ard.bmj.com
Objective Psoriatic arthritis (PsA) is a chronic inflammatory arthritis affecting up to 30% of
patients with psoriasis (Ps). To date, most of the known risk loci for PsA are shared with Ps …

The genetics of psoriasis and psoriatic arthritis

DD O'Rielly, M Jani, P Rahman, JT Elder - The Journal of Rheumatology …, 2019 - jrheum.org
Psoriatic arthritis (PsA) is an inflammatory arthritis that manifests in 20–30% of patients
diagnosed with psoriasis. Epidemiologic studies suggest a substantial genetic contribution …